MENU
 

PRE TAX NTA |$3.76

Value as at close of business on 17 January 2024

Beware the pitfalls of investing in healthcare, says IFM boss

IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.

Bannan, a portfolio manager in the $215bn IFM Investors' small caps fund, overseeing its investment in healthcare, consumer companies and technology, watches the sector carefully.

But she warns that each company can face different challenges as a result of market and regulatory factors.

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn't necessarily proven to be the case,” she says in an interview with The Australian ahead of her appearance as a stock tipper at the Sohn Hearts & Minds conference in Sydney next month.

“Even some of the defensive stocks such as radiology and pathology have had a pretty tough time over the last 18 months, with volumes lagging and companies facing higher costs given the inflationary environment.”

Pathology companies did well during Covid when they worked around the clock doing government-funded tests, but have suffered from a market downturn as fewer people visit GPs and consumers keep a closer eye on their spending. “There's been a big reduction in physical GP attendances due to telehealth,” she says.

“There is also a shortage of GPs and an affordability issue as well.”

Bannan says there is also a wide range of biotech stocks, but these can be highly risky investments.

“We still see many investment opportunities across the small caps healthcare space, but you have to be very stock-specific given the range of different sectors they are in,” she says.

She sees some areas of interest in the radiology sector, such as PET, CT and MRI screening.

At the moment, she says, the global healthcare market is closely watching the implications trials of new anti-obesity drugs.

She believes this has had a negative impact on the share price of ASX-listed ResMed, which makes sleep apnea equipment - more prevalent in people with obesity. If incidences of obesity fell away, there could be fewer incidences of sleep apnea.

“The very topical issue which is playing out overseas, but is also affecting some of the stocks on the Australian market, is what impact these anti-obesity drugs like Ozempic will have in the longer term?” Bannan says.

“The listed markets have jumped very quickly to extrapolate what these drugs could mean across the entire healthcare space.

“In the fullness of time, we'll see, and markets often overshoot. But it is something you need to keep an eye on.”

Bannan will tip an Australian small-cap stock in her appearance at the Sohn conference, but cannot reveal it until the day.

Attendees pay $3500 to go to the one-day conference - now in its eighth year in Australia - to hear the stock tips of leading fund managers from Australia and overseas, with the money raised going to support a range of medical research organisations.

Co-founders of the conference in Australia have included former UBS chief Matthew Grounds, his former UBS colleague Guy Fowler, and Sydney businessman Gary Weiss.

This year's conference is expected to bring the total funds raised for medical research by the Sohn conferences in Australia to more than $60m since the first conference in November 2016.

Funds raised will go to a range of organisations, including the Victor Chang Cardiac Research Institute, the Baker Heart and Diabetes Institute, the Cerebral Palsy Alliance Research Foundation, the University of Sydney Brain and Mind Centre, and the Florey Kids Critical Care Research at The Children's Hospital at Westmead in Sydney.

Bannan's interest in speaking at the Sohn conference stems from the death of her friend, at the age of 34, from cancer.

“I lost my best friend to cancer a few years ago and I have responsibility for the healthcare and biotech sector, so it (the Sohn conference) is something which is of great interest to me,” she says.

“I jumped at the chance when I was asked if I would like to participate.”

Bannan comes from a family with a long interest in stockmarket investing.

“I always gravitated towards subjects like business studies and economics at school,” she says.

“But, ultimately, it was my dad's influence. He started out as a chartered accountant and moved across to sell side research as an analyst. He has done that his entire career and he loves it. He always told my sister - who is also in funds management - and I that we should be doing something that's interesting, that we should try to understand how the world works.

“He thought equity markets were fascinating. The learning curve never stops.”

Bannan started her career at accounting firm KPMG, where she gained her accounting qualifications, before moving across to the sell side sector with a job at Macquarie Bank. There, she began to learn about stock analysis as well as modelling and valuing companies.

“Then the opportunity came up to move into the small-caps team at IFM and I have been here ever since,” Bannan says. 

With a history dating back to 1990, the former Industry Funds Management (now known as IFM Investors) is a fund management group founded by some of the country's largest industry super funds. It manages more than $215bn. Now owned by 17 major Australian super funds, its role as a specialist investor for superannuation funds and institutional investors has seen it expand globally. It now manages money for more than 660 institutions around the world including insurance companies, universities and sovereign wealth funds.

Bannan says any fund manager worth their salt has “got plenty of scars” from mistakes made in investment calls.

“Over the years in the job, you are constantly learning from your mistakes,” she says. “The job is about constantly fine tuning your process and evolving your thinking, and learning something every step of the way.”

Bannan says fund managers need to have the courage of their conviction about a stock and not panic when the price goes down. 

“You have to have conviction in your thesis,” she says.

“If a stock price is going against you, you have to ask: is your thesis intact? Is this a buying opportunity?

 “It is about having the conviction to stick with your call and not panicking and selling with the mob.”

Bannan also oversees IFM's investment in small-cap retail and consumer stocks.

While the Australian consumer has been remarkably resilient so far in the face of higher inflation and interest rates, she is cautious about consumer stocks.

“The consumer has been resilient. But we haven't yet seen the full impact of higher interest rates,” Bannan says.

 “Fixed-rate mortgages are still rolling off and there has been no easing up in cost-of-living pressures. And the savings that were built up through 2020 and 2021 (in the Covid lockdowns) are now largely exhausted.

 “The consumer outlook is tough, but the question is: to what extent is that price in?”

 “We have to be very selective about the stocks we are looking at, but I think there are still areas of opportunity in that space.”

 The Australian is a media partner of Sohn Hearts & Minds, which will be held at the Sydney Opera House on November 17. For information and tickets, go to sohnheartsandminds.com.au

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.


Disclaimer: This material has been prepared by The Australian, published on 10 October 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
Nine top stock picks to prepare your portfolio for 2025
Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.
Resources fundies reveal top picks ahead of ‘stellar’ 2025
Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.
Qiao Ma: finding killer companies, surviving the GFC & why founders win
Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.
10 top fund managers reveal their long-term stock picks
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 
 

Nine top stock picks to prepare your portfolio for 2025

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.

Read More
January 21st, 2025
 

Resources fundies reveal top picks ahead of ‘stellar’ 2025

Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.

Read More
January 6th, 2025
 

Qiao Ma: finding killer companies, surviving the GFC & why founders win

Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.

Read More
January 6th, 2025
 

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 

Read More
December 28th, 2024
 

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
December 19th, 2024
 

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
December 10th, 2024
 

Nick Griffin – The Nvidia story is not over

Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.

Read More
December 9th, 2024
 

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
December 5th, 2024
 

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
November 20th, 2024
 

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
November 18th, 2024
 

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
November 17th, 2024
 

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
November 15th, 2024
 

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
November 15th, 2024
 

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
November 15th, 2024
 

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15th, 2024
 

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15th, 2024
 

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15th, 2024
 

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15th, 2024
 

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
November 14th, 2024
 

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
November 9th, 2024
 

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
November 6th, 2024
 

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
November 5th, 2024
 

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
November 5th, 2024
 

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
November 5th, 2024
 

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

 

Read More
October 29th, 2024
 

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 27th, 2024
 

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024. 

Read More
October 22nd, 2024
 

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
October 21st, 2024
 

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
October 21st, 2024
 

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 14th, 2024